How is the pandemic changing patient services?
What you need to know today
John Procter, CSMS GBU VP Offering Development
Blog
Jul 30, 2020

Few industries are free from the impact of COVID-19, and that is certainly true in life sciences. For instance, services that provide support directly to patients have been limited or locked down completely, and there are many – in-person, multichannel and interventional interactions among them.

The demand to operate differently in our current environment comes with a new set of challenges – and at the top of that list is the need for appropriate space to accommodate physical distancing requirements, a huge shift that has led to a new physical and psychological normal. Many services are offered virtually, but that is not always an option. For those services requiring in-person care, there are new guidelines for facilities, health care providers (HCPs) and volunteers alike, making patient care all the more challenging, regardless of where you look.

So what could all of this mean long-term?

We are still in the early stages of assessing the impact of the pandemic, but one thing is certain: the services patients need most will likely look very different in the future. We imagine innovative new opportunities for our industry, driven by a changing health system.

At IQVIA, we have identified three important long-term impacts that the pharma industry should consider now when looking at approaches to patient services after the pandemic. Find these tips and other important information in my recent article for PME and PMLive.

You may also be interested in
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.